XEPRYLIA Trademark

Trademark Overview

On Wednesday, September 27, 2006, a trademark application was filed for XEPRYLIA with the United States Patent and Trademark Office. The USPTO has given the XEPRYLIA trademark a serial number of 79029808. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, September 28, 2016. This trademark is owned by SANOFI-AVENTIS. The XEPRYLIA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the central nervous system
xeprylia

General Information

Serial Number79029808
Word MarkXEPRYLIA
Filing DateWednesday, September 27, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, September 28, 2016
Registration Number3268637
Registration DateTuesday, July 24, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 8, 2007

Trademark Statements

Goods and Servicespharmaceutical preparations for the prevention and treatment of diseases and disorders of the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 28, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANOFI
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameSANOFI-AVENTIS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameSANOFI-AVENTIS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Thursday, October 25, 2018UNDELIVERABLE MAIL - NO ACTION TAKEN
Thursday, September 20, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, September 20, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, June 12, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, April 18, 2015GENERIC MADRID TRANSACTION SENT TO IB
Saturday, April 18, 2015GENERIC MADRID TRANSACTION CREATED
Tuesday, October 28, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 28, 2014CANCELLED SECTION 71
Saturday, July 21, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, December 11, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, September 20, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 23, 2007FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 23, 2007FINAL DISPOSITION PROCESSED
Monday, November 19, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 24, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, May 8, 2007PUBLISHED FOR OPPOSITION
Wednesday, April 18, 2007NOTICE OF PUBLICATION
Wednesday, March 14, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 14, 2007ASSIGNED TO LIE
Thursday, February 15, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 15, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 14, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 14, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 20, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 15, 2006REFUSAL PROCESSED BY IB
Wednesday, November 29, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, November 29, 2006REFUSAL PROCESSED BY MPU
Tuesday, November 28, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, November 27, 2006NON-FINAL ACTION WRITTEN
Monday, November 27, 2006ASSIGNED TO EXAMINER
Tuesday, November 14, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, November 9, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

xeprylia central nervous system disorders diseases preparations prevention treatment pharmaceutical